PEE2: THE COST-EFFECTIVENESS OF GENETIC TESTING FOR PERIODONTAL DISEASE. A PAYER'S PERSPECTIVE

@article{Higashi2001PEE2TC,
  title={PEE2: THE COST-EFFECTIVENESS OF GENETIC TESTING FOR PERIODONTAL DISEASE. A PAYER'S PERSPECTIVE},
  author={Mitchell K. Higashi and D L Veenstra and Michael A. del Aguila and Philippe Pierre Hujoel},
  journal={Value in Health},
  year={2001},
  volume={4},
  pages={118-119}
}
BACKGROUND: Genetic testing for disease predisposition is rapidly becoming available for a variety of chronic diseases, but it is not clear how the health insurance industry will make reimbursement decisions for these new diagnostics because the long-term clinical and economic benefits are unclear. A provider of dental health benefits requested assistance in assessing a genetic test for a composite interleukin-1 (IL-1) genotype. This test is being marketed to predict risk for progression of…